Analyst Recommendations

UBS analyst issues NEUTRAL recommendation for ADBE on March 13, 2026 01:09PM ET. The previous analyst recommendation was Neutral.ADBE was trading at $251.7824 at issue of the analyst...

March 13, 2026   ADBE -6.76%

BMO Capital analyst issues MARKET PERFORM recommendation for ADBE on March 13, 2026 01:12PM ET. The previous analyst recommendation was Market Perform.ADBE was trading at $251.73 at issue...

March 13, 2026   ADBE -6.76%

Cowen & Co. analyst issues HOLD recommendation for CTSH on March 13, 2026 01:27PM ET. The previous analyst recommendation was Hold.CTSH was trading at $60.62 at issue of...

March 13, 2026   CTSH 1.93%

Cowen & Co. analyst issues BUY recommendation for CVS on March 13, 2026 01:26PM ET. The previous analyst recommendation was Buy.CVS was trading at $76.755 at issue of...

March 13, 2026   CVS 1.47%

Bank of America Securities analyst issues BUY recommendation for ADBE on March 13, 2026 01:39PM ET. The previous analyst recommendation was Buy.ADBE was trading at $251.781 at issue...

March 13, 2026   ADBE -6.76%

Piper Sandler analyst issues OUTPERFORM recommendation for LI on March 13, 2026 12:35PM ET. The previous analyst recommendation was Neutral.LI was trading at $17.83 at issue of the...

March 13, 2026   LI 3.77%

Bernstein analyst issues MARKET PERFORM recommendation for LI on March 13, 2026 12:35PM ET. The previous analyst recommendation was Market Perform.LI was trading at $17.83 at issue of...

March 13, 2026   LI 3.77%

Goldman Sachs analyst issues SELL recommendation for ADBE on March 13, 2026 12:31PM ET. The previous analyst recommendation was Sell.ADBE was trading at $269.78 at issue of the...

March 13, 2026   ADBE -6.76%

KeyBanc analyst issues UNDERWEIGHT recommendation for ADBE on March 13, 2026 12:45PM ET. The previous analyst recommendation was Underweight.ADBE was trading at $269.78 at issue of the analyst...

March 13, 2026   ADBE -6.76%

Bernstein analyst issues OUTPERFORM recommendation for ADBE on March 13, 2026 12:40PM ET. The previous analyst recommendation was Outperform.ADBE was trading at $269.78 at issue of the analyst...

March 13, 2026   ADBE -6.76%